Literature DB >> 2960739

A mouse T cell product that preferentially enhances IgA production. I. Biologic characterization.

R L Coffman1, B Shrader, J Carty, T R Mosmann, M W Bond.   

Abstract

Supernatants from a subset of helper T cell clones can enhance IgA, IgE, and IgG1 production in cultures of lipopolysaccharide-stimulated, T cell-depleted spleen cells. The lymphokine interleukin (IL)-4 has been shown to cause the IgE and IgG1 enhancement produced by these supernatants. IgA enhancement, however, is mediated by a factor distinct from IL-4, although IL-4 can potentiate the effect of the IgA-enhancing factor. IgA-enhancing factor is also distinct from IL-1, IL-2, IL-3, granulocyte-macrophage colony-stimulating factor, and interferon-gamma and acts directly on B cells. Purified IgA-enhancing factor enhances IgA production three- to sixfold yet causes less than a twofold increase in other isotypes. The IgA enhancing activity is not inhibited by concentrations of interferon-gamma that inhibit IL-4 activities. In the accompanying article, we show that this IgA enhancing activity is a novel property of the lymphokine IL-5.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2960739

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  [Successful treatment of subcorneal pustular type of IgA pemphigus].

Authors:  U Raap; B Völker; H Petering; T Hashimoto; D Zillikens; A Kapp; T Werfel
Journal:  Hautarzt       Date:  2005-01       Impact factor: 0.751

2.  Infected dendritic cells are sufficient to mediate the adjuvant activity generated by Venezuelan equine encephalitis virus replicon particles.

Authors:  Daniel R Tonkin; Alan Whitmore; Robert E Johnston; Mario Barro
Journal:  Vaccine       Date:  2012-04-21       Impact factor: 3.641

3.  Expression of IL-5 receptors on B cells: role in mucosal B cell responses.

Authors:  G R Harriman; K C Allison; W Strober
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

4.  Nonsecretory IgA1 autoantibodies targeting desmosomal component desmoglein 3 in intraepidermal neutrophilic IgA dermatosis.

Authors:  J Wang; J Kwon; X Ding; J A Fairley; D T Woodley; L S Chan
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

Review 5.  A T cell/B cell/epithelial cell internet for mucosal inflammation and immunity.

Authors:  K Fujihashi; M N Kweon; H Kiyono; J L VanCott; F W van Ginkel; M Yamamoto; J R McGhee
Journal:  Springer Semin Immunopathol       Date:  1997

Review 6.  Respiratory syncytial virus vaccine development.

Authors:  Julia L Hurwitz
Journal:  Expert Rev Vaccines       Date:  2011-10       Impact factor: 5.217

7.  Immunoglobulin heavy-chain switching may be directed by prior induction of transcripts from constant-region genes.

Authors:  J Stavnezer; G Radcliffe; Y C Lin; J Nietupski; L Berggren; R Sitia; E Severinson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

8.  A case of juvenile idiopathic polyarticular arthritis complicated by IgA deficiency in 22q11 deletion syndrome.

Authors:  Satoshi Sato; Hisashi Kawashima; Kazunori Suzuki; Ryuhei Nagao; Kazumitsu Tsuyuki; Akinori Hoshika
Journal:  Rheumatol Int       Date:  2009-12-11       Impact factor: 2.631

9.  PARP-14, a member of the B aggressive lymphoma family, transduces survival signals in primary B cells.

Authors:  Sung Hoon Cho; Shreevrat Goenka; Tiina Henttinen; Prathyusha Gudapati; Arja Reinikainen; Christine M Eischen; Riitta Lahesmaa; Mark Boothby
Journal:  Blood       Date:  2009-01-15       Impact factor: 22.113

Review 10.  Role of interleukin-6 in human and mouse mucosal IgA plasma cell responses.

Authors:  J R McGhee; K Fujihashi; K W Beagley; H Kiyono
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.